Instructions for Cifran CT (tinidazole, ciprofloxacin) pills
English Product Name Cifran CT
Cifran CT
Release Form
tab, coated, 250 mg+300 mg: 10 or 100 pcs.
Description
Coated tablets 1 tab
ciprofloxacin (in the form of monohydrate hydrochloride) 250 mg
tinidazole 300 mg
10 pcs - packagings for end-of-line meshes (1) - cardboard packs
10 pcs - end-of-line mesh packages (10) - cardboard packs.
ATX codes
J01R Combinations of antibacterial drugs
Clinical and pharmacological groups / Group affiliation Cifran CT
Antiprotozoal and antibacterial combination drug
Active ingredient
ciprofloxacin (in the form of monohydrate hydrochloride)
tinidazole
Pharmacotherapeutic group Cifran CT
Antimicrobial combination agent
Pharmacological effect Cifran CT
Complex antimicrobial agent.
The antibiotic ciprofloxacin has a broad spectrum of action and is active against most aerobic gram-positive and gram-negative bacteria. It is effective against microorganisms such as coli, kleibsiella spp., salmonella typhi and other salmonella strains, mirabilis proteus, vulgaris proteus, yersinia enterocolytic, aeruginosis pseudomonas, shigella flexnery, shigella sonnei, haemophilus dukrea, hemophilus influenza, gonorrhea non-isserialgia, moraxella catarralis, vibrio cholera, bacteroids fragilis, and staphylococcus aureus (including methicillin-resistant strains), epidermidis staphylococcus, pyogenic streptococcus, pneumonia streptococcus, mycoplasma, legionella, and tuberculosis mycobacterium.
The antiprotozoal and antimicrobial agent tinidazole is an imidazole derivative and is effective against anaerobic microorganisms such as clostridia diphilie, clostridia perfringens, bacteroides phragilis, peptococcus and peptostreptococcus anaerobius.
Testimony Cifran CT
- Chronic sinusitis
- A lung abscess
- Empyema;
- Intra-abdominal infections;
- Inflammatory gynecological diseases;
- Postoperative infections with possible aerobic and anaerobic bacteria;
- Chronic osteomyelitis
- Skin and soft tissue infections
- Skin ulcers in diabetic feet
- Pressure sores
- Oral infections (including periodontitis and periostitis)
- Diarrhea or dysentery of amebic or mixed (amebic and bacterial) etiology
Method of application, course and dosage Cifran CT:
Take 250/300 mg orally twice a day or 500/600 mg twice a day.
- Nosology Cifran CT (ICD codes)
A03
Shigellosis
A06
Amoebiasis
E10.5
Insulin-dependent diabetes mellitus with peripheral circulation disorders (incl. ulcer, gangrene)
E11.5
Non-insulin-dependent diabetes mellitus with peripheral circulation disorders (incl. ulcer, gangrene)
J32
Chronic sinusitis
J85
Abscess of lung and mediastinum
J86
Pyothorax (pleural empyema)
K04
Diseases of pulp and periapical tissues (including periodontitis)
K05
Gingivitis and periodontal diseases
K10.2
Inflammatory diseases of the jaws
K12
Stomatitis and allied lesions
K65.0
Acute peritonitis (including abscess)
K81.0
Acute cholecystitis
K81.1
Chronic cholecystitis
K83.0
Cholangitis
L01
Impetigo
L02
Skin abscess, furuncle and carbuncle
L03
Cellulitis
L08.0
Pyoderma
L08.8
Other specified local infections of skin and subcutaneous tissue
L89
Decubitus ulcer/pressure area
M86
Osteomyelitis
N70
Salpingitis and oophoritis
N71
Inflammatory disease of uterus, except cervix (including endometritis, myometritis, metritis, pyometra, uterine abscess)
N72
Inflammatory disease of cervix (including cervicitis, endocervicitis, exocervicitis)
N73.5
Pelvic peritonitis female, unspecified
T79.3
Posttraumatic wound infection, not elsewhere classified